Latest News about VKTX
Recent news which mentions VKTX
3 Monster Stocks in the Making
November 23, 2024
From Motley Fool
From Benzinga
3 Things You Need to Know if You Buy Viking Therapeutics Today
November 18, 2024
Tickers
VKTX
From Motley Fool
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.
November 16, 2024
From Motley Fool
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
November 13, 2024
From Benzinga
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?
November 13, 2024
From Motley Fool
Is Viking Therapeutics a Buy on the Dip?
November 10, 2024
From Motley Fool
4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move
November 08, 2024
Tickers
VKTX
From Motley Fool
Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag
November 07, 2024
Tickers
VKTX
From Motley Fool
Why Viking Therapeutics Stock Plummeted After Soaring Today
November 04, 2024
Tickers
VKTX
From Motley Fool
Viking Therapeutics' Reveals Early-Stage From Experimental Oral Obesity Drug Showing Weight Loss And Safety
November 04, 2024
From Benzinga
Unpacking the Latest Options Trading Trends in Viking Therapeutics
October 29, 2024
Tickers
VKTX
From Benzinga
Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
October 28, 2024
From Benzinga
Could Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution?
October 27, 2024
Tickers
VKTX
From Motley Fool
Why Viking Therapeutics Stock Soared by Nearly 21% on Thursday
October 24, 2024
Tickers
VKTX
From Motley Fool
3 Health Care Stocks Moving In Thursday's Intraday Session
October 24, 2024
From Benzinga
UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday
October 24, 2024
From Benzinga
3 Growth Stocks That Have Generated 1,000% Returns Since the Last Presidential Election (and They've All Outperformed Nvidia)
October 24, 2024
From Motley Fool
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
October 23, 2024
From Benzinga
Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?
October 22, 2024
From Benzinga
Tickers
VKTX
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.